Latest Macular edema Stories
LONDON, March 26, 2015 /PRNewswire/ -- Report Details Analysis of revenues and R&D prospects for those eye drugs - you explore potentials What's the future
Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., March 25, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Lucentis (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023" market research
RnRMarketResearch.com adds “Avastin (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023” to its store. Dallas, Texas (PRWEB)
TARRYTOWN, N.Y., Feb. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
RnRMarketResearch.com adds “Diabetic Macular Edema – Pipeline Review, H1 2015” report to its store.
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
TARRYTOWN, N.Y., Jan. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
ATLANTA, Jan. 14, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
ATLANTA, Dec. 1, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
- Any of various tropical Old World birds of the family Indicatoridae, some species of which lead people or animals to the nests of wild honeybees. The birds eat the wax and larvae that remain after the nest has been destroyed for its honey.